Shin Poong Pharm signs ‘MEDICURTAIN’ supply agreement with Serbian ‘EMI Pharm’

Published: 2018-08-29 16:31:30

Updated: 2018-08-29 16:31:30

Shin Poong Pharm(CEO Jae-Man Yoo) signed a supply agreement of the anti-adhesion barrier MEDICURTAIN with EMI Pharm D.O.O.

Shin Poong Pharm said the company will exclusively supply MEDICURTAIN in Serbia and Montenegro under the agreement, and its license and patents will be owned by Shin Poong. The payment agreed for the next 7 years is total USD 1.85 million.

“With the MEDICURTAIN’s entry to...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.